-
Founded in:
1999-01-27 -
Country:
China -
Address:
No. 239, Jubao 1st Road, Songbei District, Harbin -
Tax NO.:
912301997120425839 -
Registered Funds:
63.963333 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-Glutamic acid |
It can regulate the balance of amino acid metabolism in the body, and reduce inflammation, swelling and shrinkage of the prostate.
More
It can regulate the balance of amino acid metabolism in the body, and reduce inflammation, swelling and shrinkage of the prostate. |
0265g | 56-86-0 | 17 |
| D-Alanine |
It can regulate the balance of amino acid metabolism in the body, and reduce inflammation, swelling and shrinkage of the prostate.
More
It can regulate the balance of amino acid metabolism in the body, and reduce inflammation, swelling and shrinkage of the prostate. |
01g | 338-69-2 | 8 |
| Glycine |
It can regulate the balance of amino acid metabolism in the body, and reduce inflammation, swelling and shrinkage of the prostate.
More
It can regulate the balance of amino acid metabolism in the body, and reduce inflammation, swelling and shrinkage of the prostate. |
45mg | 56-40-6 | 27 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Choline cytosine diphosphate monosodium salt |
It promotes brain metabolism and improves brain circulation by reducing cerebrovascular resistance and increasing cerebral blood flow. It also enhances the function of the ascending activation system of the brainstem reticular structure, the function of the pyramidal system, improves motor paralysis, and has a certain effect on promoting the recovery of brain function and awakening.
More
It promotes brain metabolism and improves brain circulation by reducing cerebrovascular resistance and increasing cerebral blood flow. It also enhances the function of the ascending activation system of the brainstem reticular structure, the function of the pyramidal system, improves motor paralysis, and has a certain effect on promoting the recovery of brain function and awakening. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| sulfamethoxazole，SMZ |
It competes with p-aminobenzoic acid for dihydrofolate synthase, inhibiting bacterial synthesis of dihydrofolate; when used in combination with trimethoprim and sulfadiazine, it has a dual blocking effect on the bacterial synthesis of tetrahydrofolate, enhancing the antibacterial effect and reducing drug-resistant strains.
More
It competes with p-aminobenzoic acid for dihydrofolate synthase, inhibiting bacterial synthesis of dihydrofolate; when used in combination with trimethoprim and sulfadiazine, it has a dual blocking effect on the bacterial synthesis of tetrahydrofolate, enhancing the antibacterial effect and reducing drug-resistant strains. |
0 | ||
| Sulfadiazine |
It competes with p-aminobenzoic acid for dihydrofolate synthase, inhibiting bacterial synthesis of dihydrofolate; when used in combination with trimethoprim and sulfamethoxazole, it has a dual blocking effect on the bacterial synthesis of tetrahydrofolate, enhancing the antibacterial effect and reducing drug-resistant strains.
More
It competes with p-aminobenzoic acid for dihydrofolate synthase, inhibiting bacterial synthesis of dihydrofolate; when used in combination with trimethoprim and sulfamethoxazole, it has a dual blocking effect on the bacterial synthesis of tetrahydrofolate, enhancing the antibacterial effect and reducing drug-resistant strains. |
68-35-9 | 14 | |
| Trimethoprim |
By inhibiting bacterial dihydrofolate reductase, it hinders the reduction of dihydrofolate to tetrahydrofolate; when used in combination with sulfamethoxazole and sulfadiazine, it has a dual blocking effect on the bacterial synthesis of tetrahydrofolate, enhancing the antibacterial effect and reducing drug-resistant strains.
More
By inhibiting bacterial dihydrofolate reductase, it hinders the reduction of dihydrofolate to tetrahydrofolate; when used in combination with sulfamethoxazole and sulfadiazine, it has a dual blocking effect on the bacterial synthesis of tetrahydrofolate, enhancing the antibacterial effect and reducing drug-resistant strains. |
738-70-5 | 44 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| An enzyme that activates plasminogen, extracted from fresh human urine |
This product directly acts on the endogenous fibrinolytic system, catalyzing the cleavage of plasminogen into plasmin, which can not only degrade fibrin clots, but also degrade fibrinogen, coagulation factor V and coagulation factor VIII in the blood circulation, thereby exerting a thrombolytic effect. This product has a fast onset and good effect on newly formed thrombi. This product can also increase the activity of vascular ADP enzyme, inhibit ADP-induced platelet aggregation, and prevent thrombosis.
More
This product directly acts on the endogenous fibrinolytic system, catalyzing the cleavage of plasminogen into plasmin, which can not only degrade fibrin clots, but also degrade fibrinogen, coagulation factor V and coagulation factor VIII in the blood circulation, thereby exerting a thrombolytic effect. This product has a fast onset and good effect on newly formed thrombi. This product can also increase the activity of vascular ADP enzyme, inhibit ADP-induced platelet aggregation, and prevent thrombosis. |
0 |